Urinary creatinine excretion and lean body mass

doi:10.1093/ajcn/29.12.1359

The American Journal of Clinical Nutrition

Volume 29, Issue 12, December 1976, Pages 1359-1366

https://doi.org/10.1093/ajcn/29.12.1359 Get rights and content

ABSTRACT

In a group of 34 adult and child subjects a high correlation (r = 0.988) was found between lean body mass, as determined by potassium-40 counting, and urinary creatinine excretion. The effect of technical errors was reduced by averaging the results of two or three ⁴⁰K assays on each subject, and by making consecutive 3-day collections of urine. It appears that one can make a reasonable estimate of lean body mass from urinary creatinine excretion.

References (38)

BONSNESR.W et al.
On the calorimetric determination of creatinine by the Jaffe reaction.
J. Biol. Chem.
(1945)
YOUNGC.M et al.
Body composition of pre-adolescent and adolescent girls. J. Am. Dietet. Assoc.
(1968)
VAN NIEKERKB.D.H. et al.
Urinary creatinine as an index of body composition.
J. Nutr.
(1963)
CHINNK.S.K.
Potassium and creatinine as indexes of muscle and nonmuscle protein in rats.
J. Nutr.
(1966)
BORSOOKH. et al.
The hydrolysis of phosphocreatine and the origin of urinary creatinine.
J. Biol. Chem.
(1947)
MEADORC.K et al.
Muscle mass determination by isotopic dilution of creatine-14C.
Metabolism
(1968)
MITCHELLH.H et al.
The chemical composition of the body and its bearing on the biochemistry of growth.
J. Biol. Chem.
(1945)
FORBESR.M et al.
The composition of the adult human body as determined by chamical analysis.
J. Biol. Chem.
(1953)
FORBESR.M et al.
Further studies on the gross composition and mineral elements of the adult human body.
J. Biol. Chem.
(1956)
ZORABP.A et al.
Creatinine excretion.
Lancet
(1969)

CHATTAWAYF.W et al.

The variability of creatinine excretion in normal subjects, mental patients and pregnant women. Clin. Chim. Acta

(1969)

PATERSONN.

Relative constancy of 24 hour urine volume and 24 hour creatinine output

Clin. Chim. Acta

(1967)

LEWISJ.S et al.

Variability of creatinine excretion of normal, phenylketonuric and glactosemic children, and children treated with anticonvulsant drugs.

Am. J. Clin. Nutr.

(1975)

RITCHEYS.J et al.

Vanability of creatinine excretion in pre-adolescent girls consuming a wide range of dietary nitrogen.

Am. J. Clin. Nutr.

(1973)

CRIMM.C et al.

Creatine metabolism in man: urinary creatine and creatinine excretions with creatine feeding.

J. Nutr.

(1975)

CRIMM.C et al.

Creatine metabolism in men: creatine pool size and turnover in relation to creatine intake.

J. Nutr.

(1976)

FOLINO.

Laws governing the chemical composition of urine.

Am. J. Physiol.

(1905)

Directory of Whole Body Radioactivity Monitors

Vienna: International Atomic Energy Agency, US 10.2

(1970)

FORBESG.B et al.

Effects of body size on potassium-40 measurement in the whole body counter (tilt chair technique). Health Physics

(1968)

Cited by (382)

Omentin-1 Levels and Outcomes in Incident Peritoneal Dialysis Patients
2023, Kidney Medicine
Omentin-1 is an adipokine with anti-inflammatory and cardioprotective properties. The objective of this study was to determine the prognostic role of plasma omentin-1 levels in incident peritoneal dialysis (PD) patients.
Retrospective analysis of prospective cohort.
152 incident PD patients.
Plasma omentin-1 level, adipose tissue omentin-1 messenger RNA (mRNA) expression.
Patient survival, technique survival, hospital admission, and duration of stay.
Time-to-event survival analyses; linear regression for hospitalization.
The mean age was 58.4 ± 11.7 years; 102 were men, and 92 had diabetes. There was no significant correlation between plasma omentin-1 level and its adipose tissue mRNA expression. A higher plasma omentin-1 level quartile was not associated with patient survival (P = 0.92) or technique survival (P = 0.83) but had a modest correlation with a lower number of hospital admissions (P = 0.07) and shorter duration of hospital stay (P = 0.04). In adjusted models using multivariable linear regression, a higher plasma omentin-1 level quartile remained significantly associated with fewer hospital admissions (β, -0.13; 95% CI, -0.26 to -0.002; P = 0.05) and shorter hospitalization duration (β, -0.20; 95% CI, -0.38 to -0.02; P = 0.03).
Observational study with baseline measures only.
Plasma omentin-1 level was not associated with patient survival, technique survival, or peritonitis, but higher plasma omentin-1 levels were associated with fewer hospital admissions and shorter duration of hospitalization among incident PD patients.
Circulating and Adipose Tissue Adiponectin Level and Outcomes in Incident Peritoneal Dialysis Patients
2023, Kidney Medicine
Cardiovascular disease is the major cause of mortality and morbidity in peritoneal dialysis (PD) patients. Adiponectin, a key adipokine, is related to obesity and insulin resistance. We determined the clinical and prognostic value of plasma adiponectin level and its adipose tissue messenger RNA (mRNA) expression in new PD patients.
Retrospective analysis of a prospective observational study.
152 new PD patients from a single center; 6 adults undergoing abdominal surgeries without kidney disease served as controls.
Plasma adiponectin level and its adipose tissue mRNA expression.
Body build and composition, patient and technique survival.
Adiponectin level and mRNA expression were grouped in quartiles for correlation analysis for body build and Cox regression for survival analysis.
The median plasma adiponectin level was 31.98 μg/mL (IQR, 16.81-49.49 μg/mL), and adiponectin mRNA expression in adipose tissue was 1.65 times higher than in controls (IQR, 0.98-2.63). There was a modest but statistically significant correlation between plasma adiponectin and its adipose tissue mRNA expression (r = 0.40, P < 0.001). Plasma adiponectin level inversely correlated with body mass index, waist-hip ratio, mid-arm circumference, adipose tissue mass, plasma triglyceride (r = -0.39, -0.38, -0.41, -0.38, and -0.30, respectively; P < 0.001 for all), as well as serum insulin level (r = -0.24, P = 0.005). Similar correlations were present but less marked with adipose tissue adiponectin mRNA level. Neither plasma adiponectin level nor adipose tissue adiponectin mRNA level predicted patient or technique survival.
Observational study, single center, single baseline measurement.
Plasma adiponectin level correlated with the degree of adiposity in new PD patients. However, neither plasma adiponectin level nor its adipose tissue mRNA expression was an independent prognostic indicator in kidney failure patients newly started on PD.
Population-Based Limits of Urine Creatinine Excretion
2022, Kidney International Reports
The validity of a timed urine collection is typically judged by measurement of urine creatinine excretion, but prevailing limits may be unreliable. We sought to empirically derive population-based limits of excretion for evaluating the validity of a timed urine collection.
Covariate and 24-hour urine data were obtained from 3582 participants in the Chronic Renal Insufficiency Cohort (CRIC) study, 814 participants in the Modification of Diet in Renal Disease (MDRD) study, 1010 participants in the Jackson Heart Study (JHS), and 8536 participants in the Prevention of Renal Vascular End Stage Disease (PREVEND) study. Weight, height, age, sex, and serum creatinine concentrations were evaluated as potential predictors of urine creatinine excretion using Akaike Information Criteria, R-squared values, and deviance. Bias and precision of the fitted models were assessed by analyses of residuals. Agreement between 24-hour creatinine clearance and ¹²⁵I-iothalamate clearance was assessed before and after exclusion of potentially invalid urine samples.
A best-fitting model to predict 24-hour urine creatinine excretion among the 9199 discovery cohort members included sex-specific terms for weight, height, and age (R-squared = 0.328). This model had a median bias of +4.3 mg creatinine/day (95% confidence interval −5.6, +13.3 mg/day) in 4599 validation cohort members, and 82% of observed values were within 30% of predicted model. Serum creatinine concentrations only marginally improved model precision but reduced bias in persons with advanced chronic kidney disease (CKD).
The limits of urine creatinine excretion derived here represent the most valid and representative data for appraising the adequacy of a timed urine collection.
Modeling the risk of low bone mass and osteoporosis as a function of urinary cadmium in U.S adults aged 50–79 years.
2022, Environmental Research
We developed an association model to estimate the risk of femoral neck low bone mass and osteoporosis from exposure to cadmium for women and men aged 50–79 in the U.S, as a function of the urinary cadmium (U–Cd) levels. We analyzed data from the NHANES 2005–2014 surveys and evaluated the relationship between U–Cd and femoral neck bone mineral density (BMD) using univariate and multivariate regression models with a combination of NHANES cycle, gender, age, smoking, race/ethnicity, height, body weight, body mass index, lean body mass, diabetes, kidney disease, physical activity, menopausal status, hormone replacement therapy, urinary lead, and prednisone intake as confounding variables. The regression coefficient between U–Cd and femoral neck BMD obtained with the best multivariate regression was used to develop an association model that can estimate the additional risk of low bone mass or osteoporosis in the population given a certain level of U–Cd. Results showed a linear relationship between U–Cd and BMD, conditional to body weight, where individuals with higher U–Cd had decreased BMD values. Our results do not support the hypothesis of a threshold for the effect of Cd on bone. Our model estimates that exposure to Cd results in an increase of 0.51 percentage points (CI95% 0.00, 0.92) of the population diagnosed with osteoporosis, compared to a theoretical absence of exposure. We estimate that 16% (CI95%: 0.00, 40%) of osteoporosis cases in the U.S. 50–79 aged population are a result of Cd exposure. This study presents the first continuous model estimating low bone mass and osteoporosis risk in the U.S. population given actual or potential changes in U–Cd levels. Our model will provide information to inform FDA's Closer to Zero initiative goal to reduce exposure to toxic elements.
Cadmium physiologically based pharmacokinetic (PBPK) models for forward and reverse dosimetry: Review, evaluation, and adaptation to the U.S. population
2022, Toxicology Letters
Citation Excerpt :
The KN model has been used and slightly modified by various other groups (Béchaux et al., 2014; Choudhury et al., 2001; Diamond et al., 2003; Fransson et al., 2014; Leconte et al., 2021; Qing et al., 2021; Ruiz et al., 2010). Choudhury et al. (2001) adapted the KN model in terms of growth algorithms for females and males (using the O'Flaherty, 1993 formula as a function of age and gender), Cd concentration in the kidney cortex (calculated based on Cd burden in kidney and kidney weight), and rate of creatinine excretion (based on its relationship with lean body mass using a weighted arithmetic mean from eight studies reported in Forbes and Bruining, 1976). Additionally, while the original KN model C5 parameter (fraction of GI-tract Cd retained in epithelium) was estimated as 4.8% for both women and men (Kjellstrom and Nordberg, 1978), Choudhury et al. (2001) suggested a gender difference and proposed 5% for men and 10% for women given the shown increased intestinal absorption for women caused by lower body iron stores (Järup and Åkesson, 2009).
The goal of this study was to assess a cadmium (Cd) physiologically based pharmacokinetic (PBPK) model to evaluate Cd toxicological reference values (e.g. reference dose, tolerable intake, minimum risk level) adapted to the U.S. population. We reviewed and evaluated previously published Cd PBPK models and developed further adaptations to the 1978 Kjellström and Nordberg (KN) model. Specifically, we propose adaptations with updated U.S.-specific bodyweight, kidney weight and creatinine excretion models by using NHANES data as well as a stochastic PBPK model that provides credible intervals of uncertainty around mean populational estimates. We provide our model review and adaptations as well as present estimates from the newly adapted models using observed U.S. urinary Cd values as a function of gender and age and given dietary exposure as evaluated from NHANES/WWEIA and U.S. Total Diet Study data. Results show all newly adapted models provide acceptable mean estimates of urinary Cd in the U.S. The stochastic model provides credible intervals to further inform regulatory decision making. Validation of the estimated K-Cd concentration values was not possible as data for a representative population was not available. We developed a web-based tool implementing these models and other potential adaptations to facilitate PBPK model estimate comparisons.
Urinary creatinine based equations for estimation of fat free mass in patients with intestinal insufficiency or intestinal failure
2021, Clinical Nutrition ESPEN
Assessment of body composition is an important aspect of disease management in patients with intestinal insufficiency (INS) or intestinal failure (IF). However, in daily clinical settings most body composition methods are too expensive or impractical, leaving body composition to be assessed by less reliable methods such as skin fold thickness. The aim of this study was to investigate and validate the use of an equation for the estimation of fat-free mass (FFM) with bioelectrical impedance analysis (BIA) as reference method.
A literature search for identification of urinary creatinine-based FFM-prediction equations was carried out a long side the creation of an equation by multiple linear regression. The correlation of each equation with FFM (measured by BIA in 277 patients with either INS or IF) was done by Pearson's correlation. Further investigation and validation of performance was done for the equations with the strongest correlation by Bland–Altman analysis, determination of root mean square error (RMSE), and intraclass correlation (ICC). The validation was carried out in a new group of 37 patients with either INS or IF.
A total of 11 prediction equations were correlated with FFM measured by BIA. The equation called FFMmultiple and FFM-5 had the strongest correlation (r = 0.969, p < 0.01 and r = 0.950, p < 0.01, respectively). FFMmultiple was superior to FFM-5 regarding Bland–Altman analysis, RMSE, and ICC in the study group (Mean bias ± Standard Deviation = 0.042 ± 2.352 versus 0.309 ± 3.196; 95% limits of agreement = [-4.568; 4.651] versus [-5.955; 6.578]; RMSE = 0.158 versus 0.236; ICC = 0.969 versus 0.948). Cross-validation resulted in a Bland–Altman analysis with a statistically significant difference between FFMmultiple and FFM by BIA. FFM-5 showed wide 95% limits of agreement ([-6.977; 6.421]).
Two urinary creatinine-based equations (FFMmultiple and FFM-5) showed promising results as possible substitutes to BIA, however further investigation and cross validation revealed inauspicious results. Thus, the present study cannot recommend the use of a prediction equation instead of BIA for the assessment of FFM in patients with INS and IF.

View all citing articles on Scopus

¹: Present address: Sophia Children's Hospital, Rotterdam, The Netherlands.

View full text

Urinary creatinine excretion and lean body mass

ABSTRACT

J. Biol. Chem.

J. Nutr.

J. Nutr.

J. Biol. Chem.

Metabolism

J. Biol. Chem.

J. Biol. Chem.

J. Biol. Chem.

Lancet

Clin. Chim. Acta

Am. J. Clin. Nutr.

Am. J. Clin. Nutr.

J. Nutr.

J. Nutr.

Laws governing the chemical composition of urine.

Am. J. Physiol.

Directory of Whole Body Radioactivity Monitors

Vienna: International Atomic Energy Agency, US 10.2

Effects of body size on potassium-40 measurement in the whole body counter (tilt chair technique). Health Physics